---
document_datetime: 2023-09-21 22:26:02
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/aquipta-epar-all-authorised-presentations_en.pdf
document_name: aquipta-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8083851
conversion_datetime: 2025-12-23 03:26:48.264768
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging        | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|----------------------------|-------------|
| EU/1/23/1750/001 | AQUIPTA           | 10 mg      | Tablet                | Oral use                  | blister (PVC/PE/PCTFE/alu) | 28 tablets  |
| EU/1/23/1750/002 | AQUIPTA           | 10 mg      | Tablet                | Oral use                  | blister (PVC/PE/PCTFE/alu) | 98 tablets  |
| EU/1/23/1750/003 | AQUIPTA           | 60 mg      | Tablet                | Oral use                  | blister (PVC/PE/PCTFE/alu) | 28 tablets  |
| EU/1/23/1750/004 | AQUIPTA           | 60 mg      | Tablet                | Oral use                  | blister (PVC/PE/PCTFE/alu) | 98 tablets  |